Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.93M Buy
25,380
+857
+3% +$306K 0.42% 69
2025
Q4
$8.03M Buy
24,523
+213
+0.9% +$67.6K 0.36% 71
2025
Q3
$6.86M Sell
24,310
-867
-3% -$251K 0.32% 73
2025
Q2
$7.03M Buy
25,177
+920
+4% +$261K 0.31% 79
2025
Q1
$7.56M Buy
24,257
+519
+2% +$153K 0.35% 73
2024
Q4
$6.19M Sell
23,738
-596
-2% -$177K 0.41% 59
2024
Q3
$7.84M Sell
24,334
-166
-0.7% -$54.3K 0.54% 53
2024
Q2
$7.66M Buy
24,500
+978
+4% +$287K 0.56% 52
2024
Q1
$6.69M Buy
23,522
+990
+4% +$290K 0.52% 55
2023
Q4
$6.49M Buy
22,532
+11,854
+111% +$3.23M 0.55% 51
2023
Q3
$2.87M Sell
10,678
-11,723
-52% -$2.93M 0.27% 83
2023
Q2
$4.97M Sell
22,401
-785
-3% -$182K 0.45% 58
2023
Q1
$5.61M Sell
23,186
-1,382
-6% -$339K 0.52% 56
2022
Q4
$6.45M Sell
24,568
-277
-1% -$74.3K 0.6% 53
2022
Q3
$5.6M Buy
24,845
+322
+1% +$78.1K 0.56% 53
2022
Q2
$5.97M Buy
24,523
+153
+0.6% +$37.5K 0.56% 51
2022
Q1
$5.89M Buy
24,370
+401
+2% +$92.1K 0.47% 59
2021
Q4
$5.39M Buy
23,969
+433
+2% +$91.4K 0.42% 62
2021
Q3
$5M Sell
23,536
-376
-2% -$86.5K 0.42% 66
2021
Q2
$5.83M Buy
23,912
+174
+0.7% +$42.8K 0.5% 55
2021
Q1
$5.91M Sell
23,738
-53
-0.2% -$12.6K 0.55% 51
2020
Q4
$5.47M Sell
23,791
-2,107
-8% -$486K 0.54% 53
2020
Q3
$6.58M Sell
25,898
-618
-2% -$153K 0.69% 46
2020
Q2
$6.25M Buy
26,516
+732
+3% +$167K 0.77% 41
2020
Q1
$5.23M Sell
25,784
-3,844
-13% -$840K 0.78% 41
2019
Q4
$7.14M Sell
29,628
-1,691
-5% -$373K 0.82% 41
2019
Q3
$6.06M Sell
31,319
-3,163
-9% -$607K 0.76% 49
2019
Q2
$6.36M Sell
34,482
-11,692
-25% -$2.09M 0.73% 51
2019
Q1
$8.77M Buy
46,174
+581
+1% +$111K 0.9% 40
2018
Q4
$8.88M Sell
45,593
-285
-0.6% -$55.6K 1.03% 31
2018
Q3
$9.51M Sell
45,878
-11,518
-20% -$2.27M 0.98% 35
2018
Q2
$10.6M Sell
57,396
-1,612
-3% -$285K 1.19% 21
2018
Q1
$10.1M Sell
59,008
-1,529
-3% -$281K 1.16% 21
2017
Q4
$10.5M Buy
60,537
+6,679
+12% +$1.18M 1.14% 22
2017
Q3
$10K Sell
53,858
-1,232
-2% -$218K 1.13% 19
2017
Q2
$9.49M Sell
55,090
-7,684
-12% -$1.25M 1.22% 18
2017
Q1
$10.3M Buy
62,774
+5,549
+10% +$922K 1.34% 16
2016
Q4
$8.37M Buy
57,225
+3,404
+6% +$512K 1.2% 25
2016
Q3
$8.98M Buy
53,821
+472
+0.9% +$79.8K 1.37% 18
2016
Q2
$8.12M Buy
53,349
+1,103
+2% +$171K 1.22% 23
2016
Q1
$7.83M Buy
52,246
+1,477
+3% +$219K 1.22% 22
2015
Q4
$8.24M Buy
50,769
+2,237
+5% +$352K 1.29% 18
2015
Q3
$6.71M Sell
48,532
-226
-0.5% -$35.6K 1.03% 31
2015
Q2
$7.49M Buy
48,758
+1,430
+3% +$229K 1.04% 33
2015
Q1
$7.57M Buy
47,328
+746
+2% +$117K 1.08% 26
2014
Q4
$7.42M Buy
46,582
+2,547
+6% +$397K 1.16% 24
2014
Q3
$6.18M Sell
44,035
-939
-2% -$123K 0.94% 30
2014
Q2
$5.32M Buy
44,974
+1,281
+3% +$148K 0.88% 40
2014
Q1
$5.39M Sell
43,693
-225
-0.5% -$27.3K 0.87% 38
2013
Q4
$5.01M Sell
43,918
-1,462
-3% -$166K 0.83% 42
2013
Q3
$5.08M Buy
45,380
+280
+0.6% +$30.4K 0.94% 33
2013
Q2
$4.45M Buy
+45,100
New +$4.68M 0.94% 40

Other funds holding AMGN

SouthState Corp's AMGN Position: Q1 2026 in Review

SouthState Corp increased its Amgen (AMGN) stake by 3.5% in Q1 2026, buying an estimated $306K and bringing the position to 25,380 shares worth $8.93M. The position accounts for 0.42% of the portfolio, ranked #69.

SouthState Corp first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.6M in Q2 2018. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • SouthState Corp held 25,380 shares of Amgen worth $8.93M as of Q1 2026.
  • SouthState Corp bought 857 Amgen shares in Q1 2026, an estimated $306K.
  • Amgen made up 0.42% of SouthState Corp's portfolio in Q1 2026, its #69 holding.
  • SouthState Corp first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Amgen position peaked at $10.6M in Q2 2018.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.